
Outset Medical, Inc. – NASDAQ:OM
Outset Medical stock price today
Outset Medical stock price monthly change
Outset Medical stock price quarterly change
Outset Medical stock price yearly change
Outset Medical key metrics
Market Cap | 59.37M |
Enterprise value | 825.22M |
P/E | -5.44 |
EV/Sales | 7.15 |
EV/EBITDA | -5.36 |
Price/Sales | 7.72 |
Price/Book | 3.62 |
PEG ratio | 0.28 |
EPS | -3.38 |
Revenue | 125.07M |
EBITDA | -152.76M |
Income | -168.77M |
Revenue Q/Q | -15.83% |
Revenue Y/Y | 5.73% |
Profit margin | -141.24% |
Oper. margin | -139.56% |
Gross margin | 15.46% |
EBIT margin | -139.56% |
EBITDA margin | -122.14% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeOutset Medical stock price history
Outset Medical stock forecast
Outset Medical financial statements
Jun 2023 | 36.04M | -44.04M | -122.21% |
---|---|---|---|
Sep 2023 | 30.36M | -46.18M | -152.1% |
Dec 2023 | 30.50M | -38.6M | -126.53% |
Mar 2024 | 28.16M | -39.94M | -141.81% |
Sep 2025 | 44.25M | -23.45M | -53% |
---|---|---|---|
Oct 2025 | 43.71M | -18.22M | -41.68% |
Dec 2025 | 50.23M | -15.67M | -31.21% |
Mar 2026 | 46.30M | -20.59M | -44.47% |
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 334442000 | 151.33M | 45.25% |
---|---|---|---|
Sep 2023 | 307551000 | 155.48M | 50.56% |
Dec 2023 | 313801000 | 190.91M | 60.84% |
Mar 2024 | 346242000 | 253.04M | 73.08% |
Jun 2023 | -28.17M | 27.15M | 1.04M |
---|---|---|---|
Sep 2023 | -33.99M | 29.80M | 4.10M |
Dec 2023 | -24.44M | 23.42M | 33.22M |
Mar 2024 | -45.91M | -59.03M | 68.61M |
Outset Medical alternative data
Aug 2023 | 518 |
---|---|
Sep 2023 | 518 |
Oct 2023 | 518 |
Nov 2023 | 518 |
Dec 2023 | 518 |
Jan 2024 | 518 |
Feb 2024 | 518 |
Mar 2024 | 480 |
Apr 2024 | 480 |
May 2024 | 480 |
Jun 2024 | 480 |
Jul 2024 | 480 |
Outset Medical other data
Period | Buy | Sel |
---|---|---|
Jun 2023 | 0 | 1414 |
Jul 2023 | 0 | 22405 |
Aug 2023 | 0 | 29507 |
Sep 2023 | 0 | 545 |
Nov 2023 | 0 | 11856 |
Jan 2024 | 0 | 62464 |
Feb 2024 | 0 | 18047 |
Mar 2024 | 0 | 3975 |
May 2024 | 0 | 21530 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Sale | AHMED NABEEL officer: Chief Financial Officer | Common Stock | 3,918 | $3.53 | $13,831 | ||
Sale | NASH MARC officer: SVP Operations and R&D | Common Stock | 1,097 | $3.53 | $3,872 | ||
Sale | BROTTEM JOHN L. officer: General Counsel | Common Stock | 2,972 | $3.53 | $10,491 | ||
Sale | TRIGG LESLIE director, officer.. | Common Stock | 5,237 | $3.53 | $18,487 | ||
Sale | RACINE JEAN-OLIVIER officer: Chief Technology Officer | Common Stock | 8,306 | $3.27 | $27,161 | ||
Sale | NASH MARC officer: SVP Operations and R&D | Common Stock | 2,391 | $2.13 | $5,093 | ||
Sale | AHMED NABEEL officer: Chief Financial Officer | Common Stock | 1,584 | $3.15 | $4,990 | ||
Sale | WILLIAMSON STEVEN S. officer: Chief Co.. | Common Stock | 2,500 | $3.57 | $8,925 | ||
Sale | TRIGG LESLIE director, officer.. | Common Stock | 5,320 | $3.57 | $18,992 | ||
Sale | RACINE JEAN-OLIVIER officer: Chief Technology Officer | Common Stock | 1,866 | $3.57 | $6,662 |
Patent |
---|
Application Filling date: 30 Apr 2020 Issue date: 30 Jun 2022 |
Application Filling date: 9 Nov 2021 Issue date: 12 May 2022 |
Grant Utility: Dialysis system and methods Filling date: 7 Aug 2015 Issue date: 19 Apr 2022 |
Application Filling date: 5 Aug 2021 Issue date: 10 Feb 2022 |
Application Filling date: 29 Apr 2021 Issue date: 19 Aug 2021 |
Application Filling date: 29 Apr 2021 Issue date: 12 Aug 2021 |
Application Filling date: 22 Sep 2020 Issue date: 11 Mar 2021 |
Grant Utility: Dialysis system Filling date: 9 Jan 2018 Issue date: 2 Jun 2020 |
Application Filling date: 23 Aug 2019 Issue date: 27 Feb 2020 |
Quarter | Transcript |
---|---|
Q1 2024 8 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 21 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 7 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 2 Aug 2023 | Q2 2023 Earnings Call Transcript |
Insider | Compensation |
---|---|
Ms. Leslie L. Trigg (1971) Pres, Chief Executive Officer & Director | $875,080 |
Mr. Steven S. Williamson (1973) Chief Commercial Officer | $445,440 |
Outset Medical Faces Regulatory Delays Amid Heavy Cash Burn (Rating Downgrade)
Outset Medical: Expansive TAM, Yet Profitability Remains Distant
Outset Medical: Revising To Buy, Market Dynamics, Guidance As Catalysts (Upgrade)
Outset Medical: Tablo Ship Hold A Key Overhang To Unlock Risk Capital
Outset Medical: Continues To Impress
-
What's the price of Outset Medical stock today?
One share of Outset Medical stock can currently be purchased for approximately $13.35.
-
When is Outset Medical's next earnings date?
Unfortunately, Outset Medical's (OM) next earnings date is currently unknown.
-
Does Outset Medical pay dividends?
No, Outset Medical does not pay dividends.
-
How much money does Outset Medical make?
Outset Medical has a market capitalization of 59.37M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 13% to 130.38M US dollars.
-
What is Outset Medical's stock symbol?
Outset Medical, Inc. is traded on the NASDAQ under the ticker symbol "OM".
-
What is Outset Medical's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Outset Medical?
Shares of Outset Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Outset Medical's key executives?
Outset Medical's management team includes the following people:
- Ms. Leslie L. Trigg Pres, Chief Executive Officer & Director(age: 54, pay: $875,080)
- Mr. Steven S. Williamson Chief Commercial Officer(age: 52, pay: $445,440)
-
How many employees does Outset Medical have?
As Jul 2024, Outset Medical employs 480 workers.
-
When Outset Medical went public?
Outset Medical, Inc. is publicly traded company for more then 4 years since IPO on 15 Sep 2020.
-
What is Outset Medical's official website?
The official website for Outset Medical is outsetmedical.com.
-
Where are Outset Medical's headquarters?
Outset Medical is headquartered at 3052 Orchard Drive, San Jose, CA.
-
How can i contact Outset Medical?
Outset Medical's mailing address is 3052 Orchard Drive, San Jose, CA and company can be reached via phone at +66 92 318 200.
Outset Medical company profile:

Outset Medical, Inc.
outsetmedical.comNASDAQ
480
Medical - Devices
Healthcare
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
San Jose, CA 95134
CIK: 0001484612
ISIN: US6901451079
CUSIP: 690145107